Skip to content

Mankind Pharma#39;s Rs 4,326-cr public issue keeps analysts upbeat on local flavour

The company has priced the issue in the range of Rs 1,026-1,080 per share. It mobilised Rs 1,297.9 crore from a clutch of anchor investors including CPPIB, GIC, ADIA, Fidelity, Goldman Sachs and Blackrock

Read More

​ The company has priced the issue in the range of Rs 1,026-1,080 per share. It mobilised Rs 1,297.9 crore from a clutch of anchor investors including CPPIB, GIC, ADIA, Fidelity, Goldman Sachs and Blackrock The company has priced the issue in the range of Rs 1,026-1,080 per share. It mobilised Rs 1,297.9 crore from a clutch of anchor investors including CPPIB, GIC, ADIA, Fidelity, Goldman Sachs and Blackrock  Moneycontrol Latest News Read More  

Leave a Reply

Your email address will not be published. Required fields are marked *

en_USEnglish